Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 72162-2634
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 72162-2634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (Lbl721622634)
The text provides important information about a medication called decitabine. Each vial contains 50 mg of decitabine. Reconstitution is done with sterile water, resulting in a concentration of 5 mg per mL. Further dilution is required before administration. The final concentration should be 5 mg/mL with a pH of 6.7 to 7.3. Storage instructions include keeping the vials at 25°C (77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication is for intravenous infusion only and is classified as a cytotoxic agent. Unused portions must be discarded, and the medication should be kept out of reach of children. Detailed instructions can be obtained by scanning the package insert QR code for indications, reconstitution information, dosage information, and precautions.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.